Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Systemic methotrexate therapy for psoriasis: past, present and future.

Dogra S, Mahajan R.

Clin Exp Dermatol. 2013 Aug;38(6):573-88. doi: 10.1111/ced.12062. Review.

PMID:
23837932
2.

Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.

Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A.

Rheumatology (Oxford). 2009 May;48(5):569-72. doi: 10.1093/rheumatology/kep023. Epub 2009 Mar 9.

PMID:
19273538
3.

Short-term methotrexate therapy in psoriasis: a study of 197 patients.

Kumar B, Saraswat A, Kaur I.

Int J Dermatol. 2002 Jul;41(7):444-8.

PMID:
12121564
4.

Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.

Montaudié H, Sbidian E, Paul C, Maza A, Gallini A, Aractingi S, Aubin F, Bachelez H, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Richard MA, Ortonne JP.

J Eur Acad Dermatol Venereol. 2011 May;25 Suppl 2:12-8. doi: 10.1111/j.1468-3083.2011.03991.x. Review.

PMID:
21388454
5.

Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.

Haustein UF, Rytter M.

J Eur Acad Dermatol Venereol. 2000 Sep;14(5):382-8.

PMID:
11305380
6.

Use of methotrexate in patients with psoriasis.

Kuhn A, Ruland V, Patsinakidis N, Luger TA.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S138-44. Epub 2010 Nov 2. Review.

PMID:
21044448
7.

Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.

Carneiro SC, Cássia FF, Lamy F, Chagas VL, Ramos-e-Silva M.

J Eur Acad Dermatol Venereol. 2008 Jan;22(1):25-9. doi: 10.1111/j.1468-3083.2007.02322.x.

PMID:
18181969
8.

[Methotrexate therapy in psoriasis].

Bournerias I.

Rev Prat. 2004 Jan 15;54(1):52-5. Review. French.

PMID:
15049601
9.

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.

Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS.

J Am Acad Dermatol. 2005 Feb;52(2):262-7. Review. Erratum in: J Am Acad Dermatol. 2005 Apr;52(4):670. Prodanowich, Srdjan [corrected to Prodanovich, Srdjan].

PMID:
15692471
10.

A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.

Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.

J Eur Acad Dermatol Venereol. 2008 Jan;22(1):19-24. Epub 2007 Nov 19.

PMID:
18031504
11.
12.

Systemic methotrexate for the treatment of psoriasis.

Yélamos O, Puig L.

Expert Rev Clin Immunol. 2015 May;11(5):553-63. doi: 10.1586/1744666X.2015.1026894. Epub 2015 Mar 16. Review.

PMID:
25779551
13.

Methotrexate and other chemotherapeutic agents used to treat psoriasis.

Jeffes EW 3rd, Weinstein GD.

Dermatol Clin. 1995 Oct;13(4):875-90. Review.

PMID:
8785891
14.

Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.

Boffa MJ, Chalmers RJ, Haboubi NY, Shomaf M, Mitchell DM.

Br J Dermatol. 1995 Nov;133(5):774-8.

PMID:
8555032
15.
16.

Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.

Salim A, Tan E, Ilchyshyn A, Berth-Jones J.

Br J Dermatol. 2006 Jun;154(6):1169-74.

PMID:
16704650
17.
18.

Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.

Chládek J, Grim J, Martínková J, Simková M, Vanìèková J, Koudelková V, Noièková M.

Br J Clin Pharmacol. 2002 Aug;54(2):147-56.

19.
20.

The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.

vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.

Br J Dermatol. 1996 Mar;134(3):481-7.

PMID:
8731673

Supplemental Content

Support Center